Characteristics of Turkish children with Type 2 diabetes at onset: a multicentre, cross‐sectional study

Aims To describe the baseline clinical and laboratory findings and treatment modalities of 367 children and adolescents diagnosed with Type 2 diabetes in various paediatric endocrinology centres in Turkey. Methods A standard questionnaire regarding clinical and laboratory characteristics at onset wa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetic medicine 2019-10, Vol.36 (10), p.1243-1250
Hauptverfasser: Hatun, S., Yesiltepe Mutlu, G., Cinaz, P., Turan, S., Ekberzade, A., Bereket, A., Erbas, M. Y., Akcay, T., Onal, H., Bolu, S., Arslanoglu, I., Doger, E., Yilmaz, A. A., Ucakturk, A., Karabulut, G. S., Tuhan, H. Ü., Demir, K., Erdeve, S. S., Aycan, Z., Nalbantoğlu, Ö., Kara, C., Gungor, N.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1250
container_issue 10
container_start_page 1243
container_title Diabetic medicine
container_volume 36
creator Hatun, S.
Yesiltepe Mutlu, G.
Cinaz, P.
Turan, S.
Ekberzade, A.
Bereket, A.
Erbas, M. Y.
Akcay, T.
Onal, H.
Bolu, S.
Arslanoglu, I.
Doger, E.
Yilmaz, A. A.
Ucakturk, A.
Karabulut, G. S.
Tuhan, H. Ü.
Demir, K.
Erdeve, S. S.
Aycan, Z.
Nalbantoğlu, Ö.
Kara, C.
Gungor, N.
description Aims To describe the baseline clinical and laboratory findings and treatment modalities of 367 children and adolescents diagnosed with Type 2 diabetes in various paediatric endocrinology centres in Turkey. Methods A standard questionnaire regarding clinical and laboratory characteristics at onset was uploaded to an online national database system. Data for 367 children (aged 6–18 years) newly diagnosed with Type 2 diabetes at 37 different paediatric endocrinology centres were analysed. Results After exclusion of the children with a BMI Z‐score < 1 SD, those with genetic syndromes associated with Type 2 diabetes, and those whose C‐peptide and/or insulin levels were not available, 227 cases were included in the study. Mean age was 13.8 ± 2.2 (range 6.5–17.8) years, with female preponderance (68%). Family history of Type 2 diabetes was positive in 86% of the children. The mean BMI was 31.3 ± 6.5 kg/m2 (range 18.7–61) and BMI Z‐score was 2.4 ± 0.8 (range 1–5). More than half (57%) of the children were identified by an opportunistic diabetes screening due to existing risk markers without typical symptoms of diabetes. Only 13% (n = 29) were treated solely by lifestyle modification, while 40.5% (n = 92) were treated with metformin, 13% (n = 30) were treated with insulin, and 33.5% (n = 76) were treated with a combination of insulin and metformin initially. Mean HbA1C levels of the insulin and combination of insulin and metformin groups were 98 (11.1%) and 102 mmol/mol (11.5%), respectively, and also were significantly higher than the lifestyle modification only and metformin groups mean HbA1C levels (70(8.6%) and 67 mmol/mol (8.3%), respectively). Conclusions An opportunistic screening of children who are at high risk of Type 2 diabetes is essential, as our data showed that > 50% of the children were asymptomatic at diagnosis. The other important result of our study was the high rate of exclusion from the initial registration (38%), suggesting that accurate diagnosis of Type 2 diabetes in youth is still problematic, even for paediatric endocrinologists. What's new? Female gender and positive family history were strongly associated with Type 2 diabetes in Turkish children as well as children in western countries. More than half (57%) of the participants were identified by opportunistic diabetes screening due to existing risk markers, without typical symptoms of diabetes. Approximately half of the children (47%) with Type 2 diabetes were treated with insulin while
doi_str_mv 10.1111/dme.14038
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2232069255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2291888478</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3888-8ab983e9e9fa0db9cd6967674ebce45f172eb00de0a5f1537afe42bed138d61e3</originalsourceid><addsrcrecordid>eNp10ElKBDEUBuAgirbDwgtIwI2CZWeqIe6kHUFx066LVPKKjtbQJimkdx7BM3oSo926EMwmBL78vPcjtE_JKY1nbFo4pYLwYg2NqMhEkgpJ19GI5IIlnOR0C217_0QIZZLLTbTFKZGS5HKE7GSmnNIBnPXBao_7Gk8H92z9DOuZbYyDDr_aMMPTxRwww8aqCgJ4rALuOw_hDCvcDk38DF1wcIK1673_eHv3oIPtO9VgHwaz2EUbtWo87K3uHfR4dTmd3CR3D9e3k_O7RPOiKJJCVbLgIEHWiphKapPJLM9yAZUGkdY0Z1ARYoCo-Eh5rmoQrAJDeWEyCnwHHS1z565_GcCHsrVeQ9OoDvrBl4xxRjLJ0jTSwz_0qR9cnPhLSRrHEXkR1fFSfS_moC7nzrbKLUpKyq_-y9h_-d1_tAerxKFqwfzKn8IjGC_Bq21g8X9SeXF_uYz8BIxmkLQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2291888478</pqid></control><display><type>article</type><title>Characteristics of Turkish children with Type 2 diabetes at onset: a multicentre, cross‐sectional study</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Hatun, S. ; Yesiltepe Mutlu, G. ; Cinaz, P. ; Turan, S. ; Ekberzade, A. ; Bereket, A. ; Erbas, M. Y. ; Akcay, T. ; Onal, H. ; Bolu, S. ; Arslanoglu, I. ; Doger, E. ; Yilmaz, A. A. ; Ucakturk, A. ; Karabulut, G. S. ; Tuhan, H. Ü. ; Demir, K. ; Erdeve, S. S. ; Aycan, Z. ; Nalbantoğlu, Ö. ; Kara, C. ; Gungor, N.</creator><creatorcontrib>Hatun, S. ; Yesiltepe Mutlu, G. ; Cinaz, P. ; Turan, S. ; Ekberzade, A. ; Bereket, A. ; Erbas, M. Y. ; Akcay, T. ; Onal, H. ; Bolu, S. ; Arslanoglu, I. ; Doger, E. ; Yilmaz, A. A. ; Ucakturk, A. ; Karabulut, G. S. ; Tuhan, H. Ü. ; Demir, K. ; Erdeve, S. S. ; Aycan, Z. ; Nalbantoğlu, Ö. ; Kara, C. ; Gungor, N. ; turkish type 2 diabetes research group ; the turkish type 2 diabetes research group</creatorcontrib><description>Aims To describe the baseline clinical and laboratory findings and treatment modalities of 367 children and adolescents diagnosed with Type 2 diabetes in various paediatric endocrinology centres in Turkey. Methods A standard questionnaire regarding clinical and laboratory characteristics at onset was uploaded to an online national database system. Data for 367 children (aged 6–18 years) newly diagnosed with Type 2 diabetes at 37 different paediatric endocrinology centres were analysed. Results After exclusion of the children with a BMI Z‐score &lt; 1 SD, those with genetic syndromes associated with Type 2 diabetes, and those whose C‐peptide and/or insulin levels were not available, 227 cases were included in the study. Mean age was 13.8 ± 2.2 (range 6.5–17.8) years, with female preponderance (68%). Family history of Type 2 diabetes was positive in 86% of the children. The mean BMI was 31.3 ± 6.5 kg/m2 (range 18.7–61) and BMI Z‐score was 2.4 ± 0.8 (range 1–5). More than half (57%) of the children were identified by an opportunistic diabetes screening due to existing risk markers without typical symptoms of diabetes. Only 13% (n = 29) were treated solely by lifestyle modification, while 40.5% (n = 92) were treated with metformin, 13% (n = 30) were treated with insulin, and 33.5% (n = 76) were treated with a combination of insulin and metformin initially. Mean HbA1C levels of the insulin and combination of insulin and metformin groups were 98 (11.1%) and 102 mmol/mol (11.5%), respectively, and also were significantly higher than the lifestyle modification only and metformin groups mean HbA1C levels (70(8.6%) and 67 mmol/mol (8.3%), respectively). Conclusions An opportunistic screening of children who are at high risk of Type 2 diabetes is essential, as our data showed that &gt; 50% of the children were asymptomatic at diagnosis. The other important result of our study was the high rate of exclusion from the initial registration (38%), suggesting that accurate diagnosis of Type 2 diabetes in youth is still problematic, even for paediatric endocrinologists. What's new? Female gender and positive family history were strongly associated with Type 2 diabetes in Turkish children as well as children in western countries. More than half (57%) of the participants were identified by opportunistic diabetes screening due to existing risk markers, without typical symptoms of diabetes. Approximately half of the children (47%) with Type 2 diabetes were treated with insulin while only 13% were treated solely by lifestyle modification.</description><identifier>ISSN: 0742-3071</identifier><identifier>EISSN: 1464-5491</identifier><identifier>DOI: 10.1111/dme.14038</identifier><identifier>PMID: 31099079</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Adolescents ; Children ; Cross-sectional studies ; Diabetes ; Diabetes mellitus ; Diabetes mellitus (non-insulin dependent) ; Diagnosis ; Endocrinology ; Insulin ; Laboratories ; Metformin ; Pediatrics</subject><ispartof>Diabetic medicine, 2019-10, Vol.36 (10), p.1243-1250</ispartof><rights>2019 Diabetes UK</rights><rights>2019 Diabetes UK.</rights><rights>Diabetic Medicine © 2019 Diabetes UK</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3888-8ab983e9e9fa0db9cd6967674ebce45f172eb00de0a5f1537afe42bed138d61e3</citedby><cites>FETCH-LOGICAL-c3888-8ab983e9e9fa0db9cd6967674ebce45f172eb00de0a5f1537afe42bed138d61e3</cites><orcidid>0000-0003-3919-7763</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fdme.14038$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fdme.14038$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31099079$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hatun, S.</creatorcontrib><creatorcontrib>Yesiltepe Mutlu, G.</creatorcontrib><creatorcontrib>Cinaz, P.</creatorcontrib><creatorcontrib>Turan, S.</creatorcontrib><creatorcontrib>Ekberzade, A.</creatorcontrib><creatorcontrib>Bereket, A.</creatorcontrib><creatorcontrib>Erbas, M. Y.</creatorcontrib><creatorcontrib>Akcay, T.</creatorcontrib><creatorcontrib>Onal, H.</creatorcontrib><creatorcontrib>Bolu, S.</creatorcontrib><creatorcontrib>Arslanoglu, I.</creatorcontrib><creatorcontrib>Doger, E.</creatorcontrib><creatorcontrib>Yilmaz, A. A.</creatorcontrib><creatorcontrib>Ucakturk, A.</creatorcontrib><creatorcontrib>Karabulut, G. S.</creatorcontrib><creatorcontrib>Tuhan, H. Ü.</creatorcontrib><creatorcontrib>Demir, K.</creatorcontrib><creatorcontrib>Erdeve, S. S.</creatorcontrib><creatorcontrib>Aycan, Z.</creatorcontrib><creatorcontrib>Nalbantoğlu, Ö.</creatorcontrib><creatorcontrib>Kara, C.</creatorcontrib><creatorcontrib>Gungor, N.</creatorcontrib><creatorcontrib>turkish type 2 diabetes research group</creatorcontrib><creatorcontrib>the turkish type 2 diabetes research group</creatorcontrib><title>Characteristics of Turkish children with Type 2 diabetes at onset: a multicentre, cross‐sectional study</title><title>Diabetic medicine</title><addtitle>Diabet Med</addtitle><description>Aims To describe the baseline clinical and laboratory findings and treatment modalities of 367 children and adolescents diagnosed with Type 2 diabetes in various paediatric endocrinology centres in Turkey. Methods A standard questionnaire regarding clinical and laboratory characteristics at onset was uploaded to an online national database system. Data for 367 children (aged 6–18 years) newly diagnosed with Type 2 diabetes at 37 different paediatric endocrinology centres were analysed. Results After exclusion of the children with a BMI Z‐score &lt; 1 SD, those with genetic syndromes associated with Type 2 diabetes, and those whose C‐peptide and/or insulin levels were not available, 227 cases were included in the study. Mean age was 13.8 ± 2.2 (range 6.5–17.8) years, with female preponderance (68%). Family history of Type 2 diabetes was positive in 86% of the children. The mean BMI was 31.3 ± 6.5 kg/m2 (range 18.7–61) and BMI Z‐score was 2.4 ± 0.8 (range 1–5). More than half (57%) of the children were identified by an opportunistic diabetes screening due to existing risk markers without typical symptoms of diabetes. Only 13% (n = 29) were treated solely by lifestyle modification, while 40.5% (n = 92) were treated with metformin, 13% (n = 30) were treated with insulin, and 33.5% (n = 76) were treated with a combination of insulin and metformin initially. Mean HbA1C levels of the insulin and combination of insulin and metformin groups were 98 (11.1%) and 102 mmol/mol (11.5%), respectively, and also were significantly higher than the lifestyle modification only and metformin groups mean HbA1C levels (70(8.6%) and 67 mmol/mol (8.3%), respectively). Conclusions An opportunistic screening of children who are at high risk of Type 2 diabetes is essential, as our data showed that &gt; 50% of the children were asymptomatic at diagnosis. The other important result of our study was the high rate of exclusion from the initial registration (38%), suggesting that accurate diagnosis of Type 2 diabetes in youth is still problematic, even for paediatric endocrinologists. What's new? Female gender and positive family history were strongly associated with Type 2 diabetes in Turkish children as well as children in western countries. More than half (57%) of the participants were identified by opportunistic diabetes screening due to existing risk markers, without typical symptoms of diabetes. Approximately half of the children (47%) with Type 2 diabetes were treated with insulin while only 13% were treated solely by lifestyle modification.</description><subject>Adolescents</subject><subject>Children</subject><subject>Cross-sectional studies</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diabetes mellitus (non-insulin dependent)</subject><subject>Diagnosis</subject><subject>Endocrinology</subject><subject>Insulin</subject><subject>Laboratories</subject><subject>Metformin</subject><subject>Pediatrics</subject><issn>0742-3071</issn><issn>1464-5491</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp10ElKBDEUBuAgirbDwgtIwI2CZWeqIe6kHUFx066LVPKKjtbQJimkdx7BM3oSo926EMwmBL78vPcjtE_JKY1nbFo4pYLwYg2NqMhEkgpJ19GI5IIlnOR0C217_0QIZZLLTbTFKZGS5HKE7GSmnNIBnPXBao_7Gk8H92z9DOuZbYyDDr_aMMPTxRwww8aqCgJ4rALuOw_hDCvcDk38DF1wcIK1673_eHv3oIPtO9VgHwaz2EUbtWo87K3uHfR4dTmd3CR3D9e3k_O7RPOiKJJCVbLgIEHWiphKapPJLM9yAZUGkdY0Z1ARYoCo-Eh5rmoQrAJDeWEyCnwHHS1z565_GcCHsrVeQ9OoDvrBl4xxRjLJ0jTSwz_0qR9cnPhLSRrHEXkR1fFSfS_moC7nzrbKLUpKyq_-y9h_-d1_tAerxKFqwfzKn8IjGC_Bq21g8X9SeXF_uYz8BIxmkLQ</recordid><startdate>201910</startdate><enddate>201910</enddate><creator>Hatun, S.</creator><creator>Yesiltepe Mutlu, G.</creator><creator>Cinaz, P.</creator><creator>Turan, S.</creator><creator>Ekberzade, A.</creator><creator>Bereket, A.</creator><creator>Erbas, M. Y.</creator><creator>Akcay, T.</creator><creator>Onal, H.</creator><creator>Bolu, S.</creator><creator>Arslanoglu, I.</creator><creator>Doger, E.</creator><creator>Yilmaz, A. A.</creator><creator>Ucakturk, A.</creator><creator>Karabulut, G. S.</creator><creator>Tuhan, H. Ü.</creator><creator>Demir, K.</creator><creator>Erdeve, S. S.</creator><creator>Aycan, Z.</creator><creator>Nalbantoğlu, Ö.</creator><creator>Kara, C.</creator><creator>Gungor, N.</creator><general>Wiley Subscription Services, Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-3919-7763</orcidid></search><sort><creationdate>201910</creationdate><title>Characteristics of Turkish children with Type 2 diabetes at onset: a multicentre, cross‐sectional study</title><author>Hatun, S. ; Yesiltepe Mutlu, G. ; Cinaz, P. ; Turan, S. ; Ekberzade, A. ; Bereket, A. ; Erbas, M. Y. ; Akcay, T. ; Onal, H. ; Bolu, S. ; Arslanoglu, I. ; Doger, E. ; Yilmaz, A. A. ; Ucakturk, A. ; Karabulut, G. S. ; Tuhan, H. Ü. ; Demir, K. ; Erdeve, S. S. ; Aycan, Z. ; Nalbantoğlu, Ö. ; Kara, C. ; Gungor, N.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3888-8ab983e9e9fa0db9cd6967674ebce45f172eb00de0a5f1537afe42bed138d61e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Adolescents</topic><topic>Children</topic><topic>Cross-sectional studies</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diabetes mellitus (non-insulin dependent)</topic><topic>Diagnosis</topic><topic>Endocrinology</topic><topic>Insulin</topic><topic>Laboratories</topic><topic>Metformin</topic><topic>Pediatrics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hatun, S.</creatorcontrib><creatorcontrib>Yesiltepe Mutlu, G.</creatorcontrib><creatorcontrib>Cinaz, P.</creatorcontrib><creatorcontrib>Turan, S.</creatorcontrib><creatorcontrib>Ekberzade, A.</creatorcontrib><creatorcontrib>Bereket, A.</creatorcontrib><creatorcontrib>Erbas, M. Y.</creatorcontrib><creatorcontrib>Akcay, T.</creatorcontrib><creatorcontrib>Onal, H.</creatorcontrib><creatorcontrib>Bolu, S.</creatorcontrib><creatorcontrib>Arslanoglu, I.</creatorcontrib><creatorcontrib>Doger, E.</creatorcontrib><creatorcontrib>Yilmaz, A. A.</creatorcontrib><creatorcontrib>Ucakturk, A.</creatorcontrib><creatorcontrib>Karabulut, G. S.</creatorcontrib><creatorcontrib>Tuhan, H. Ü.</creatorcontrib><creatorcontrib>Demir, K.</creatorcontrib><creatorcontrib>Erdeve, S. S.</creatorcontrib><creatorcontrib>Aycan, Z.</creatorcontrib><creatorcontrib>Nalbantoğlu, Ö.</creatorcontrib><creatorcontrib>Kara, C.</creatorcontrib><creatorcontrib>Gungor, N.</creatorcontrib><creatorcontrib>turkish type 2 diabetes research group</creatorcontrib><creatorcontrib>the turkish type 2 diabetes research group</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hatun, S.</au><au>Yesiltepe Mutlu, G.</au><au>Cinaz, P.</au><au>Turan, S.</au><au>Ekberzade, A.</au><au>Bereket, A.</au><au>Erbas, M. Y.</au><au>Akcay, T.</au><au>Onal, H.</au><au>Bolu, S.</au><au>Arslanoglu, I.</au><au>Doger, E.</au><au>Yilmaz, A. A.</au><au>Ucakturk, A.</au><au>Karabulut, G. S.</au><au>Tuhan, H. Ü.</au><au>Demir, K.</au><au>Erdeve, S. S.</au><au>Aycan, Z.</au><au>Nalbantoğlu, Ö.</au><au>Kara, C.</au><au>Gungor, N.</au><aucorp>turkish type 2 diabetes research group</aucorp><aucorp>the turkish type 2 diabetes research group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Characteristics of Turkish children with Type 2 diabetes at onset: a multicentre, cross‐sectional study</atitle><jtitle>Diabetic medicine</jtitle><addtitle>Diabet Med</addtitle><date>2019-10</date><risdate>2019</risdate><volume>36</volume><issue>10</issue><spage>1243</spage><epage>1250</epage><pages>1243-1250</pages><issn>0742-3071</issn><eissn>1464-5491</eissn><abstract>Aims To describe the baseline clinical and laboratory findings and treatment modalities of 367 children and adolescents diagnosed with Type 2 diabetes in various paediatric endocrinology centres in Turkey. Methods A standard questionnaire regarding clinical and laboratory characteristics at onset was uploaded to an online national database system. Data for 367 children (aged 6–18 years) newly diagnosed with Type 2 diabetes at 37 different paediatric endocrinology centres were analysed. Results After exclusion of the children with a BMI Z‐score &lt; 1 SD, those with genetic syndromes associated with Type 2 diabetes, and those whose C‐peptide and/or insulin levels were not available, 227 cases were included in the study. Mean age was 13.8 ± 2.2 (range 6.5–17.8) years, with female preponderance (68%). Family history of Type 2 diabetes was positive in 86% of the children. The mean BMI was 31.3 ± 6.5 kg/m2 (range 18.7–61) and BMI Z‐score was 2.4 ± 0.8 (range 1–5). More than half (57%) of the children were identified by an opportunistic diabetes screening due to existing risk markers without typical symptoms of diabetes. Only 13% (n = 29) were treated solely by lifestyle modification, while 40.5% (n = 92) were treated with metformin, 13% (n = 30) were treated with insulin, and 33.5% (n = 76) were treated with a combination of insulin and metformin initially. Mean HbA1C levels of the insulin and combination of insulin and metformin groups were 98 (11.1%) and 102 mmol/mol (11.5%), respectively, and also were significantly higher than the lifestyle modification only and metformin groups mean HbA1C levels (70(8.6%) and 67 mmol/mol (8.3%), respectively). Conclusions An opportunistic screening of children who are at high risk of Type 2 diabetes is essential, as our data showed that &gt; 50% of the children were asymptomatic at diagnosis. The other important result of our study was the high rate of exclusion from the initial registration (38%), suggesting that accurate diagnosis of Type 2 diabetes in youth is still problematic, even for paediatric endocrinologists. What's new? Female gender and positive family history were strongly associated with Type 2 diabetes in Turkish children as well as children in western countries. More than half (57%) of the participants were identified by opportunistic diabetes screening due to existing risk markers, without typical symptoms of diabetes. Approximately half of the children (47%) with Type 2 diabetes were treated with insulin while only 13% were treated solely by lifestyle modification.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>31099079</pmid><doi>10.1111/dme.14038</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-3919-7763</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0742-3071
ispartof Diabetic medicine, 2019-10, Vol.36 (10), p.1243-1250
issn 0742-3071
1464-5491
language eng
recordid cdi_proquest_miscellaneous_2232069255
source Wiley Online Library Journals Frontfile Complete
subjects Adolescents
Children
Cross-sectional studies
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Diagnosis
Endocrinology
Insulin
Laboratories
Metformin
Pediatrics
title Characteristics of Turkish children with Type 2 diabetes at onset: a multicentre, cross‐sectional study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T15%3A33%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Characteristics%20of%20Turkish%20children%20with%20Type%202%20diabetes%20at%20onset:%20a%20multicentre,%20cross%E2%80%90sectional%20study&rft.jtitle=Diabetic%20medicine&rft.au=Hatun,%20S.&rft.aucorp=turkish%20type%202%20diabetes%20research%20group&rft.date=2019-10&rft.volume=36&rft.issue=10&rft.spage=1243&rft.epage=1250&rft.pages=1243-1250&rft.issn=0742-3071&rft.eissn=1464-5491&rft_id=info:doi/10.1111/dme.14038&rft_dat=%3Cproquest_cross%3E2291888478%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2291888478&rft_id=info:pmid/31099079&rfr_iscdi=true